U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress
America has long been the global leader in rare disease drug development but this leadership is at risk unless Congress protects key incentives In […]
U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress Read More »